United Kingdom· GB-APID-45296311000001108
Filspari 400mg tablets
A sparsentan product containing sparsentan, registered in United Kingdom by Vifor Pharma UK Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Sparsentan is registered in 10 of 19 countries.
Countries holding a registration under ATC C09XX01 (sparsentan), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Sparsentan · ATC C09XX01
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Sparsentan
- Manufacturer
- Vifor Pharma UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- C09XX01
- ATC class
- Sparsentan
- Defined daily dose
- 0.4 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin7640114725548
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sparsentan in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFILSPARIVifor France, Paris
- SwitzerlandFilspari 200 mg, FilmtablettenVifor (International) Inc.
- FinlandFILSPARIVifor France
- United StatesFILSPARITravere Therapeutics, Inc.
- SpainFILSPARI 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULAVifor France
- BelgiumFilspari 200 mgVifor France
- IrelandFilspari 200 mg film-coated tabletsVifor France
- IcelandFilspariVifor France
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Filspari
- Liechtenstein · Filspari
- Norway · Filspari
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e27e2152-6be6-46f5-874a-2196dc67fd50 GET /v1/drugs/e27e2152-6be6-46f5-874a-2196dc67fd50?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45296311000001108",
"desc": "Filspari 400mg tablets (Vifor Pharma UK Ltd)",
"form": "Oral tablet",
"vpid": "45342811000001102",
"source": "dmd",
"vtm_id": "45337711000001108",
"strength": "400 mg",
"substance": "Sparsentan",
"ingredient": "Sparsentan",
"supplier_code": "18549711000001107"
}See everything about sparsentan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.